ArticleCancers2023

Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy.

Miriam Möller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.